CML [electronic resource] : genetic paradigm of targeted therapy, part 1 of 2 / Michael W. Deininger.
Material type:
FilmSeries: Henry Stewart talksBiomedical & life sciences collection. Cancer genetics: Publisher: London : Henry Stewart Talks, 2015Description: 1 online resource (1 streaming video file (24 min.) : color, sound)Other title: Chronic myeloid leukemia : genetic paradigm of targeted therapy. Part 1 | CML : genetic paradigm of targeted therapy. Part 1Subject(s): Antineoplastic agents | Cancer -- Genetic aspects | Chronic myeloid leukemia | Drug delivery systems | Protein kinases -- Inhibitors | Antineoplastic Agents -- pharmacology | Drug Delivery Systems | Fusion Proteins, bcr-abl -- antagonists & inhibitors | imatinib | Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- drug therapy | Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- genetics | Molecular Targeted Therapy -- methods | Philadelphia Chromosome -- drug effects | Protein Kinase Inhibitors | Protein-Tyrosine Kinases -- antagonists & inhibitors | Translocation, GeneticOnline resources: Click here to access online | Series Animated audio-visual presentation with synchronized narration.
Title from title frames.
Contents: Typical clinical findings and phases of chronic myeloid leukaemia (CML) -- Philadelphia chromosome (juxtaposition & genomic anatomy BCR-ABL1) -- Target cells for transformation -- Molecular driver for pathogenesis (BCR-ABL1 tyrosine kinase) -- Imatinib (inhibitor of BCR-ABL1).
Access restricted to subscribers.
Mode of access: World Wide Web.